Bank of New York Mellon’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-232,424
| Closed | -$31.7M | – | 4286 |
|
|
2020
Q3 | $31.7M | Sell |
232,424
-736
| -0.3% | -$78.3K | 0.01% | 1175 |
|
|
2020
Q2 | $22.5M | Buy |
233,160
+29,398
| +14% | +$2.45M | 0.01% | 1379 |
|
|
2020
Q1 | $9.55M | Sell |
203,762
-7,948
| -4% | -$509K | ﹤0.01% | 1725 |
|
|
2019
Q4 | $15.4M | Buy |
211,710
+22,395
| +12% | +$1.36M | ﹤0.01% | 1718 |
|
|
2019
Q3 | $9.87M | Sell |
189,315
-3,730
| -2% | -$198K | ﹤0.01% | 1945 |
|
|
2019
Q2 | $9.68M | Buy |
193,045
+27,167
| +16% | +$1.32M | ﹤0.01% | 1982 |
|
|
2019
Q1 | $8.62M | Buy |
165,878
+11,131
| +7% | +$513K | ﹤0.01% | 2047 |
|
|
2018
Q4 | $7.56M | Buy |
154,747
+1,413
| +0.9% | +$77.8K | ﹤0.01% | 2063 |
|
|
2018
Q3 | $10M | Buy |
153,334
+22,816
| +17% | +$1.34M | ﹤0.01% | 2024 |
|
|
2018
Q2 | $6.48M | Buy |
130,518
+24,290
| +23% | +$1.18M | ﹤0.01% | 2250 |
|
|
2018
Q1 | $5.18M | Buy |
106,228
+18,707
| +21% | +$972K | ﹤0.01% | 2333 |
|
|
2017
Q4 | $3.68M | Sell |
87,521
-21,133
| -19% | -$814K | ﹤0.01% | 2499 |
|
|
2017
Q3 | $4.66M | Buy |
108,654
+45,446
| +72% | +$1.45M | ﹤0.01% | 2364 |
|
|
2017
Q2 | $828K | Buy |
63,208
+6,603
| +12% | +$87K | ﹤0.01% | 3359 |
|
|
2017
Q1 | $744K | Buy |
56,605
+8,469
| +18% | +$108K | ﹤0.01% | 3401 |
|
|
2016
Q4 | $623K | Buy |
48,136
+18,146
| +61% | +$280K | ﹤0.01% | 3493 |
|
|
2016
Q3 | $491K | Buy |
29,990
+8,487
| +39% | +$153K | ﹤0.01% | 3548 |
|
|
2016
Q2 | $267K | Buy |
21,503
+9,861
| +85% | +$123K | ﹤0.01% | 3792 |
|
|
2016
Q1 | $125K | Buy |
+11,642
| New | +$106K | ﹤0.01% | 3915 |
|
Bank of New York Mellon's MYOK Position: Q4 2020 in Review
Bank of New York Mellon sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 232,424 shares — an estimated $31.7M sold.
Bank of New York Mellon first reported a position in MYOK in Q1 2016 and held it in 19 quarters. The position peaked at $31.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Bank of New York Mellon reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Bank of New York Mellon sold 232,424 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $31.7M.
- Bank of New York Mellon first reported a position in MyoKardia, Inc. Common Stock in Q1 2016 and held it in 19 quarters.
- Bank of New York Mellon's MyoKardia, Inc. Common Stock position peaked at $31.7M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Bank of New York Mellon's 13F filing for Q4 2020, filed 9 Feb 2021.